China Pharma Holdings Price to Sales Ratio 2010-2023 | CPHI
Historical PS ratio values for China Pharma Holdings (CPHI) over the last 10 years. The current P/S ratio for China Pharma Holdings as of April 26, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| China Pharma Holdings P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-04-26 |
0.30 |
|
0.10 |
| 2023-12-31 |
0.61 |
$3.08 |
0.20 |
| 2023-09-30 |
0.74 |
$5.23 |
0.14 |
| 2023-06-30 |
1.71 |
$6.51 |
0.26 |
| 2023-03-31 |
1.95 |
$7.62 |
0.26 |
| 2022-12-31 |
4.80 |
$8.10 |
0.59 |
| 2022-09-30 |
6.50 |
$8.45 |
0.77 |
| 2022-06-30 |
10.73 |
$8.64 |
1.24 |
| 2022-03-31 |
19.50 |
$9.63 |
2.03 |
| 2021-12-31 |
24.13 |
$10.52 |
2.29 |
| 2021-09-30 |
27.93 |
$10.75 |
2.60 |
| 2021-06-30 |
36.16 |
$12.92 |
2.80 |
| 2021-03-31 |
42.00 |
$12.30 |
3.42 |
| 2020-12-31 |
22.29 |
$13.21 |
1.69 |
| 2020-06-30 |
33.32 |
$12.57 |
2.65 |
| 2020-03-31 |
25.20 |
$11.20 |
2.25 |
| 2019-12-31 |
11.84 |
$12.53 |
0.94 |
| 2019-09-30 |
12.26 |
$11.79 |
1.04 |
| 2019-06-30 |
16.17 |
$12.78 |
1.26 |
| 2019-03-31 |
16.59 |
$12.47 |
1.33 |
| 2020-09-30 |
18.24 |
$12.75 |
1.43 |
| 2018-12-31 |
12.87 |
$14.15 |
0.91 |
| 2018-09-30 |
10.21 |
$14.84 |
0.69 |
| 2018-06-30 |
11.00 |
$15.83 |
0.69 |
| 2018-03-31 |
15.86 |
$15.54 |
1.02 |
| 2017-12-31 |
8.78 |
$15.16 |
0.58 |
| 2017-09-30 |
8.75 |
$16.78 |
0.52 |
| 2017-06-30 |
11.50 |
$16.74 |
0.69 |
| 2017-03-31 |
13.00 |
$17.46 |
0.74 |
| 2016-12-31 |
13.00 |
$18.85 |
0.69 |
| 2016-09-30 |
10.75 |
$17.96 |
0.60 |
| 2016-06-30 |
12.00 |
$20.88 |
0.57 |
| 2015-12-31 |
7.85 |
$23.35 |
0.34 |
| 2015-09-30 |
9.92 |
$22.00 |
0.45 |
| 2015-06-30 |
18.00 |
$21.04 |
0.86 |
| 2015-03-31 |
17.00 |
$20.92 |
0.81 |
| 2014-12-31 |
15.01 |
$21.42 |
0.70 |
| 2016-03-31 |
8.50 |
$25.75 |
0.33 |
| 2014-09-30 |
12.55 |
$31.23 |
0.40 |
| 2014-06-30 |
19.25 |
$34.15 |
0.56 |
| 2014-03-31 |
25.25 |
$36.33 |
0.70 |
| 2013-12-31 |
17.25 |
$37.64 |
0.46 |
| 2013-09-30 |
14.00 |
$41.35 |
0.34 |
| 2013-06-30 |
10.50 |
$46.01 |
0.23 |
| 2013-03-31 |
14.50 |
$53.56 |
0.27 |
| 2012-12-31 |
10.10 |
$62.57 |
0.16 |
| 2012-09-30 |
18.25 |
$75.03 |
0.24 |
| 2012-06-30 |
17.00 |
$85.16 |
0.20 |
| 2012-03-31 |
34.00 |
$90.96 |
0.37 |
| 2011-12-31 |
33.50 |
$93.35 |
0.36 |
| 2011-09-30 |
48.50 |
$95.07 |
0.51 |
| 2011-06-30 |
112.50 |
$92.48 |
1.22 |
| 2011-03-31 |
126.50 |
$89.04 |
1.42 |
| 2010-12-31 |
151.50 |
$85.49 |
1.77 |
| 2010-09-30 |
124.50 |
$81.11 |
1.53 |
| 2010-06-30 |
137.50 |
$77.95 |
1.76 |
| 2010-03-31 |
166.50 |
$74.92 |
2.22 |
| 2009-12-31 |
192.50 |
$72.96 |
2.64 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.004B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
